- In April 2023, Bio-Rad Laboratories, Inc. announced the release of its enhanced QX ONE Droplet Digital PCR System, designed for automated, high-throughput applications in clinical research and molecular diagnostics. The system offers streamlined workflows and improved multiplexing capabilities, addressing the growing demand for precise and scalable quantification in oncology, infectious disease testing, and gene expression studies. This innovation reflects Bio-Rad's continued commitment to advancing digital PCR solutions for both clinical and research users
- In March 2023, QIAGEN N.V. expanded its digital PCR portfolio with the introduction of new assays for liquid biopsy-based cancer detection. These assays are optimized for QIAcuity systems and support highly sensitive mutation detection in circulating tumor DNA. This development enhances QIAGEN's precision diagnostics offerings and demonstrates its strategic focus on personalized medicine and minimally invasive testing technologies
- In March 2023, Stilla Technologies unveiled its new Naica Prism system at the Molecular Med Tri-Con 2023 conference. The next-generation digital PCR system provides high-resolution imaging and multiplex detection for applications in oncology, infectious diseases, and environmental testing. With improved automation and AI-integrated software, the Naica Prism addresses the growing demand for efficient and user-friendly dPCR platforms, reinforcing Stilla’s innovation-driven growth in the diagnostics space
- In February 2023, Thermo Fisher Scientific Inc. announced the launch of new digital PCR reagents compatible with its QuantStudio Absolute Q system. These reagents enhance sensitivity and assay performance for detecting rare genetic events and low-level pathogens. This advancement is part of Thermo Fisher’s strategy to provide end-to-end solutions in the molecular diagnostics market, meeting the evolving needs of clinical laboratories and pharmaceutical researchers
- In January 2023, RainDance Technologies (acquired by Bio-Rad) partnered with academic institutions to explore ultra-sensitive detection of viral pathogens using digital PCR in wastewater surveillance. This initiative highlights the increasing relevance of digital PCR in public health monitoring and environmental applications, illustrating its versatility beyond traditional clinical diagnostics. The collaboration underscores the broader application potential of dPCR as global health systems strengthen surveillance capabilities
